No Data
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
Exagen Announces Board Resignation and Committee Restructuring
Exagen Is Maintained at Buy by Canaccord Genuity
Exagen Price Target Cut to $8.00/Share From $10.00 by Canaccord Genuity
CCORF Maintains Exagen(XGN.US) With Buy Rating, Cuts Target Price to $8
A Quick Look at Today's Ratings for Exagen(XGN.US), With a Forecast Between $8 to $10